TY - JOUR
T1 - A universal glycoenzyme biosynthesis pipeline that enables efficient cell-free remodeling of glycans
AU - Jaroentomeechai, Thapakorn
AU - Kwon, Yong Hyun
AU - Liu, Yiwen
AU - Young, Olivia
AU - Bhawal, Ruchika
AU - Wilson, Joshua D.
AU - Li, Mingji
AU - Chapla, Digantkumar G.
AU - Moremen, Kelley W.
AU - Jewett, Michael C.
AU - Mizrachi, Dario
AU - DeLisa, Matthew P.
N1 - Funding Information:
We would like to thank Dr Bernard Henrissat for providing statistical data of the GT genes from the CAZy database. We thank Dr Scott Emr for providing the yeast strain and corresponding expression vector used in these studies. We thank Dr Sudeep Banjade, Dr May Taw, and Dr Morgan Ludwicki for their assistance and critical discussions regarding mammalian cell expression. We thank Dr Yimon Aye and Dr Weston Kightlinger for critical discussions of the manuscript and Dr Ashty Karim (ORCID# 0000-0002-5789-7715) for scientific communication consultation. This work was supported by the Bill and Melinda Gates Foundation (OPP1217652 to M.P.D. and M.C.J.), Defense Threat Reduction Agency (HDTRA1-15-10052 and HDTRA1-20-10004 to M.P.D. and M.C.J.), National Science Foundation (CBET-1159581, CBET-1264701, CBET-1936823 to M.P.D. and MCB-1413563 to M.P.D. and M.C.J.), and National Institutes of Health (1R01GM137314 and 1R01GM127578 to M.P.D. and R01GM130915 to K.W.M.). The work was also supported by seed project funding (to M.P.D.) through the National Institutes of Health-funded Cornell Center on the Physics of Cancer Metabolism (supporting grant 1U54CA210184). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. T.J. was supported by a Royal Thai Government Fellowship and a Cornell Fleming Graduate Scholarship.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - The ability to reconstitute natural glycosylation pathways or prototype entirely new ones from scratch is hampered by the limited availability of functional glycoenzymes, many of which are membrane proteins that fail to express in heterologous hosts. Here, we describe a strategy for topologically converting membrane-bound glycosyltransferases (GTs) into water soluble biocatalysts, which are expressed at high levels in the cytoplasm of living cells with retention of biological activity. We demonstrate the universality of the approach through facile production of 98 difficult-to-express GTs, predominantly of human origin, across several commonly used expression platforms. Using a subset of these water-soluble enzymes, we perform structural remodeling of both free and protein-linked glycans including those found on the monoclonal antibody therapeutic trastuzumab. Overall, our strategy for rationally redesigning GTs provides an effective and versatile biosynthetic route to large quantities of diverse, enzymatically active GTs, which should find use in structure-function studies as well as in biochemical and biomedical applications involving complex glycomolecules.
AB - The ability to reconstitute natural glycosylation pathways or prototype entirely new ones from scratch is hampered by the limited availability of functional glycoenzymes, many of which are membrane proteins that fail to express in heterologous hosts. Here, we describe a strategy for topologically converting membrane-bound glycosyltransferases (GTs) into water soluble biocatalysts, which are expressed at high levels in the cytoplasm of living cells with retention of biological activity. We demonstrate the universality of the approach through facile production of 98 difficult-to-express GTs, predominantly of human origin, across several commonly used expression platforms. Using a subset of these water-soluble enzymes, we perform structural remodeling of both free and protein-linked glycans including those found on the monoclonal antibody therapeutic trastuzumab. Overall, our strategy for rationally redesigning GTs provides an effective and versatile biosynthetic route to large quantities of diverse, enzymatically active GTs, which should find use in structure-function studies as well as in biochemical and biomedical applications involving complex glycomolecules.
UR - http://www.scopus.com/inward/record.url?scp=85140441914&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140441914&partnerID=8YFLogxK
U2 - 10.1038/s41467-022-34029-7
DO - 10.1038/s41467-022-34029-7
M3 - Article
C2 - 36280670
AN - SCOPUS:85140441914
SN - 2041-1723
VL - 13
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 6325
ER -